OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30103755

Shanghai Baolijia Chemical Co Ltd

Commodity ChemicalsVerified

Shanghai Baolijia Chemical Co Ltd operates with a debt-to-equity ratio of 2.63, indicating a capital structure heavily reliant on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.73, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow is negative at -69.5 million CNY, and capital expenditures are -59.7 million CNY, indicating ongoing investment in operations but with no net cash generation. Profitability metrics show a return on equity of -9.69% and a return on assets of -2.43%, both significantly below the typical performance of the Commodity Chemicals industry. These negative returns suggest operational inefficiencies or declining margins, which are concerning for a company in a capital-intensive sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic and regulatory risks. The company's growth trajectory is uncertain, with no clear revenue growth or margin expansion in recent periods. The operating income is negative at -47.8 million CNY, and net income is also negative at -55.4 million CNY, indicating a lack of profitability and potential operational challenges. Risk factors include a high debt load, with long-term debt of 1.5 billion CNY, and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution events reported in the latest filings. However, the company's financial flexibility is constrained by its high leverage and negative cash flow. Recent filings and transcripts do not indicate any major strategic shifts or new product launches. The company's focus appears to be on managing its debt and improving operational efficiency, but no material progress has been disclosed in the latest financial statements.

30-day price · 301037+2.40 (+16.4%)
Low$13.64High$17.76Close$17.01As of15 May, 00:00 UTC
Profile
CompanyShanghai Baolijia Chemical Co Ltd
Ticker301037.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shanghai Baolijia Chemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily serving industrial and consumer markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a high confidence level of 0.92 based on verified market data.

Shanghai Baolijia Chemical Co Ltd operates with a debt-to-equity ratio of 2.63, indicating a capital structure heavily reliant on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.73, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow is negative at -69.5 million CNY, and capital expenditures are -59.7 million CNY, indicating ongoing investment in operations but with no net cash generation. Profitability metrics show a return on equity of -9.69% and a return on assets of -2.43%, both significantly below the typical performance of the Commodity Chemicals industry. These negative returns suggest operational inefficiencies or declining margins, which are concerning for a company in a capital-intensive sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic and regulatory risks. The company's growth trajectory is uncertain, with no clear revenue growth or margin expansion in recent periods. The operating income is negative at -47.8 million CNY, and net income is also negative at -55.4 million CNY, indicating a lack of profitability and potential operational challenges. Risk factors include a high debt load, with long-term debt of 1.5 billion CNY, and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution events reported in the latest filings. However, the company's financial flexibility is constrained by its high leverage and negative cash flow. Recent filings and transcripts do not indicate any major strategic shifts or new product launches. The company's focus appears to be on managing its debt and improving operational efficiency, but no material progress has been disclosed in the latest financial statements.
Key takeaways
  • The company is operating at a loss, with negative net income and operating income.
  • High debt levels and a negative free cash flow suggest financial stress and limited liquidity.
  • The company's profitability metrics are significantly below industry norms, indicating operational challenges.
  • There is no clear evidence of diversification in business segments or geographic markets.
  • The company's growth outlook is uncertain, with no material revenue or margin expansion in recent periods.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.69B
Gross profit$210.6M
Operating income-$47.8M
Net income-$55.4M
R&D
SG&A
D&A
SBC
Operating cash flow$60.3M
CapEx-$59.7M
Free cash flow-$69.5M
Total assets$2.28B
Total liabilities$1.70B
Total equity$572.2M
Cash & equivalents
Long-term debt$1.51B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$572.2M
Net cash-$1.51B
Current ratio0.7
Debt/Equity2.6
ROA-2.4%
ROE-9.7%
Cash conversion-1.1%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric301037Activity
Op margin-2.8%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-3.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin12.5%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity263.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 15:42 UTC#63320003
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 15:44 UTCJob: 16ac92d3